China NMPA Product Recall - hip joint femoral head

MicroPort Orthopedics Inc., in conjunction with its Chinese subsidiary Shanghai MicroPort Orthopedics Medical Technology Co., Ltd., has initiated a voluntary Class II recall for its femoral head of hip joint implants. This action, publicly announced by the National Medical Products Administration (NMPA) on June 14, 2023, addresses a critical issue of incorrect labeling information identified on certain product batches. The core problem revolves around discrepancies in labeling, rather than a defect in the physical integrity or function of the implant itself. A Class II recall designation by regulatory authorities signifies that while the issue is serious enough to warrant a recall, the probability of severe adverse health consequences from using or being exposed to the violative product is either remote or the health consequences are temporary and reversible. As a required action, MicroPort Orthopedics Inc. is actively retrieving the affected medical devices from the market. Comprehensive details, including the specific models, specifications, and batch numbers of the recalled femoral heads, are meticulously outlined in an accompanying "Medical Device Recall Event Report Form." This document is accessible through the NMPA's official website, providing essential guidance for healthcare providers and distributors. This proactive measure underscores the company's commitment to regulatory compliance and ensuring the highest standards of product accuracy and patient safety.